The 2020 European Society of Cardiology (ESC) guidelines for non-ST elevation acute coronary syndrome (NSTE-ACS)provide impactful thrombotic risk criteria to help clinicians understand the management of patients undergoing percutaneous coronary intervention (PCI) in categories with a significant risk of major adverse cardiac events (MACE), a new analysis shows.